What is MedAvail Holdings, Inc. (MDVLQ) stock price today?

MedAvail Holdings, Inc. (MDVLQ) is currently trading at $0.00.

What is MDVLQ P/E ratio?

MedAvail Holdings, Inc.'s P/E ratio is -0.05. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is MDVLQ return on equity (ROE)?

MedAvail Holdings, Inc.'s return on equity (ROE) is -194.67%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is MedAvail Holdings, Inc.'s market cap?

MedAvail Holdings, Inc. has a market capitalization of $161.

OTC · Medical - Pharmaceuticals

MedAvail Holdings, Inc. (MDVLQ) Stock

$0.00 OTC: MDVLQ Healthcare

MedAvail Holdings, Inc. operated as a technology-driven provider of retail pharmacy services and solutions across the United States and Canada.

Valuation

Metric	Value
Price	$0.00
Market Cap	$161
P/E Ratio	-0.05
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$-35.56
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-194.67%
ROA	-68.15%
ROCE	-170.73%
Gross Margin	5.18%
Operating Margin	-106.98%
Net Margin	-106.16%
Debt/Equity	0.10
Current Ratio	6.51

Annual Financials (USD)

Metric	2018	2019	2020	2021	2022
Revenue	$0	$4.0M	$14.0M	$22.0M	$43.0M
Operating Profit	$-4.0M	$-21.0M	$-21.0M	$-44.0M	$-46.0M
Net Profit	$-3.0M	$-22.0M	$-27.0M	$-44.0M	$-48.0M
EPS	$-270.89	$-340.88	$-234.27	$-67.09	$-36.20
Op Margin	-1202.5%	-552.7%	-149.0%	-196.6%	-107.7%

Balance Sheet (USD)

Metric	2018	2019	2020	2021	2022
Total Assets	$4.0M	$18.0M	$69.0M	$38.0M	$33.0M
Total Liabilities	$2.0M	$115.0M	$8.0M	$19.0M	$12.0M
Cash	$0	$9.0M	$58.0M	$20.0M	$11.0M
Borrowings	$1.0M	$14.0M	$3.0M	$12.0M	$7.0M

Cash Flow (USD)

Metric	2018	2019	2020	2021	2022
Operating Cash Flow	$-3.0M	$-20.0M	$-29.0M	$-43.0M	$-48.0M
Investing Cash Flow	$0	$-1.0M	$-2.0M	$-7.0M	$-5.0M
Financing Cash Flow	$0	$0	$-5.0M	$-1.0M	$0
Net Cash Flow	$-1.0M	$5.0M	$49.0M	$-38.0M	$-8.0M
Free Cash Flow	$-3.0M	$-20.0M	$-29.0M	$-46.0M	$-50.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	0.03
FCF Yield	-1720.05%
Quick Ratio	2.86
Interest Coverage	-39.61
Return 1Y	0.00%
Return 3Y	-100.00%
Return 5Y	—

Ownership

Insiders Held0.00%

Institutions Held0.00%

Institutions Float Held0.00%

Institutional Holder	Shares	Report Date
Ameriflex Group, Inc.	124	2025-09-30

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BIOCQBiocept, Inc.	$0.00	—	-0.01	$525	0.00%
BSPMBiostar Pharmaceuticals, Inc.	$0.00	—	0.00	$264	0.00%
ELOXEloxx Pharmaceuticals, Inc.	$13.74	-9.49%	-9.79	$47.21M	0.00%
HLTHQCue Health Inc.	$0.00	—	0.00	$1591	0.00%
HTGMQHTG Molecular Diagnostics, Inc.	$0.00	—	0.00	$221	0.00%

About MedAvail Holdings, Inc.

MedAvail Holdings, Inc. operated as a technology-driven provider of retail pharmacy services and solutions across the United States and Canada. The company specialized in developing and bringing to market self-service pharmacy systems, mobile applications, and kiosk-based solutions. A primary offering was the MedAvail MedCenter, an advanced pharmacy technology designed to facilitate on-site prescription dispensing. This system allowed for direct medication access in various settings, including medical clinics, retail environments, and employer sites, utilizing an audio-visual link that provided real-time supervision and consultation from a licensed pharmacist during dispensing. The corporate headquarters for MedAvail Holdings, Inc. were situated in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc., along with its affiliated entities, submitted a voluntary petition for Chapter 7 liquidation to the U.S. Bankruptcy Court for the District of Delaware.

MedAvail Holdings, Inc. (MDVLQ) stock trades at $0.00 with a market capitalization of $161. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.05, reflecting a net loss over the last twelve months, price-to-book of 0.00, price-to-sales of 0.00.

On profitability, MedAvail Holdings, Inc. generates a return on equity (ROE) of -194.67% (negative, reflecting a net loss), return on capital employed of -170.73%, an operating margin of -106.98%, a net profit margin of -106.16%.

Official website: medavail.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.